Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G4A | P47712 | 1/20 | 0.51 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.49 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.49 |
| ▸ | RARB | P10826 | 1/20 | 0.49 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.47 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.47 |
| ▸ | THRA | P10827 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21628502 | 1.00 | PLA2G4A (0.51) | PLA2G4ALPAR1LPAR5RARBS1PR1 | |
| SCHEMBL21628516 | 0.99 | LPAR1 (0.50) | PLA2G4ALPAR1LPAR5RARBS1PR1 | |
| SCHEMBL21628432 | 0.95 | LPAR1 (0.51) | PLA2G4ALPAR1LPAR5RARBS1PR1 | |
| SCHEMBL21628398 | 0.91 | SLC6A2 (0.50) | LPAR1LPAR5S1PR1S1PR3SLC6A2 | |
| SCHEMBL21628866 | 0.87 | RARB (0.65) | LPAR1LPAR5RARB | |
| SCHEMBL21657028 | 0.86 | ICAM1 (0.52) | PLA2G4ARARBS1PR1S1PR3 | |
| SCHEMBL21628540 | 0.86 | RARB (0.62) | LPAR1LPAR5RARBS1PR1S1PR3 | |
| SCHEMBL21628585 | 0.86 | SLC6A2 (0.55) | LPAR1LPAR5SLC6A2SLC6A4 | |
| SCHEMBL21628573 | 0.85 | MDH1 (0.51) | LPAR1LPAR5RARBS1PR1S1PR3 | |
| SCHEMBL21628639 | 0.85 | S1PR1 (0.52) | PLA2G4ALPAR1LPAR5RARBS1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220348535-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2022-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220348535-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | PLA2G4A 4624/4885LPAR1 3936/4885LPAR5 4070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.